Yuchen Zhang
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction: Tumor-derived exosomal tsRNA 3'tiRNA-AlaCGC in promoting fibroblast senescence and Galectin-9 secretion to induce immune tolerance in lung adenocarcinoma.
Journal: Cell death discovery
Published: January 13, 2026
Targeting IRF1-TRIM21 axis enhances anti-tumor immunity by promoting ubiquitin-mediated degradation of FGL1 in non-small cell lung cancer.
Journal: Communications biology
Published: October 10, 2025
tRF3a-MetCAT Promotes EGFR-Targeted Therapeutic Resistance through the TRIM21-STAT1-C5a Axis in Lung Adenocarcinoma.
Journal: Research (Washington, D.C.)
Published: July 01, 2025
Clinicopathological characteristics and prognosis analysis of stage IB non-small cell lung cancer-a retrospective study from a Chinese medical center.
Journal: Journal of thoracic disease
Published: May 28, 2025
Tumor-derived exosomal tsRNA 3'tiRNA-AlaCGC in promoting fibroblast senescence and Galectin-9 secretion to induce immune tolerance in lung adenocarcinoma.
Journal: Cell death discovery
Published: March 11, 2025
Conjoint analysis of succinylome and phosphorylome reveals imbalanced HDAC phosphorylation-driven succinylayion dynamic contibutes to lung cancer.
Journal: Briefings in bioinformatics
Published: April 16, 2024
ACAT1 regulates tertiary lymphoid structures and correlates with immunotherapy response in non-small cell lung cancer.
Journal: The Journal of clinical investigation
Published: March 26, 2024
Major pathological response obtained after neoadjuvant chemotherapy combined with dual immunotherapy for malignant pleural mesothelioma: a case report.
Journal: Translational lung cancer research
Published: February 28, 2024
MNT inhibits lung adenocarcinoma ferroptosis and chemosensitivity by suppressing SAT1.
Journal: Communications biology
Published: September 14, 2023
FGL1 in plasma extracellular vesicles is correlated with clinical stage of lung adenocarcinoma and anti-PD-L1 response.
Journal: Clinical and experimental immunology
Published: August 03, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026